title: Shedding light on the asparaginase galaxy.
abstract: In this issue of Blood, Tong et al have reported that therapeutic drug monitoring (TDM) of asparaginase (ASP) activity levels in plasma may be an important tool for the optimization of its therapeutic effects in pediatric acute lymphoblastic leukemia (ALL).
authors.affiliation: SAN GERARDO HOSPITAL.
authors.forename: Carmelo
authors.initials: C
authors.lastname: Rizzari
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage* / Q000276:immunology*; D016903:Drug Monitoring; D004885:Erwinia / Q000201:enzymology*; D005260:Female; D006801:Humans; D008297:Male; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D011092:Polyethylene Glycols; C042705:pegaspargase; D001215:Asparaginase